4556 Stock Overview
Engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 1/6 |
KAINOS Laboratories, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,203.00 |
52 Week High | JP¥1,289.00 |
52 Week Low | JP¥1,055.00 |
Beta | 0 |
11 Month Change | -0.50% |
3 Month Change | 3.26% |
1 Year Change | 10.57% |
33 Year Change | 14.14% |
5 Year Change | 25.44% |
Change since IPO | 9.36% |
Recent News & Updates
Recent updates
Shareholder Returns
4556 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | -0.7% | -0.6% | -0.4% |
1Y | 10.6% | 16.8% | 11.4% |
Return vs Industry: 4556 underperformed the JP Medical Equipment industry which returned 16.8% over the past year.
Return vs Market: 4556 matched the JP Market which returned 11.4% over the past year.
Price Volatility
4556 volatility | |
---|---|
4556 Average Weekly Movement | 2.8% |
Medical Equipment Industry Average Movement | 3.8% |
Market Average Movement | 3.8% |
10% most volatile stocks in JP Market | 7.6% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4556 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4556's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1975 | n/a | Yukihiro Nagatsu | www.kainos.co.jp |
KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Test Kit, a liquid form creatinine measurement reagent kit for various makes of automatic analyzer systems; Aqua-auto Kainos ALB Test Kit, a liquid form reagent kit; and Aqua-auto Kainos UN-II Test Kit, a liquid urea nitrogen measurement reagent kit.
KAINOS Laboratories, Inc. Fundamentals Summary
4556 fundamental statistics | |
---|---|
Market cap | JP¥5.35b |
Earnings (TTM) | JP¥82.76m |
Revenue (TTM) | JP¥4.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs 4556 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4556 income statement (TTM) | |
---|---|
Revenue | JP¥4.44b |
Cost of Revenue | JP¥2.89b |
Gross Profit | JP¥1.55b |
Other Expenses | JP¥1.47b |
Earnings | JP¥82.76m |
Last Reported Earnings
Dec 31, 2010
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 4556 perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yieldn/a
Payout RatioDoes 4556 pay a reliable dividends?
See 4556 dividend history and benchmarksKAINOS Laboratories dividend dates | |
---|---|
Ex Dividend Date | Mar 28 2025 |
Dividend Pay Date | Jun 23 2025 |
Days until Ex dividend | 126 days |
Days until Dividend pay date | 213 days |
Does 4556 pay a reliable dividends?
See 4556 dividend history and benchmarks